Form 4 for ABT Abbott Laboratories
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0001415889-21-003804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-05 | 2021-08-03 | ABT | Karam Sammy | SVP | M - OptEx | $75.90 | +8,000 | 30.9K | +35% | +$607.2K |
| D | 2021-08-05 | 2021-08-03 | ABT | Karam Sammy | SVP | S - Sale+OE | $122.50 | -8,000 | 22.9K | -26% | -$980.0K |
| D | 2021-08-05 | 2021-08-03 | ABT | Karam Sammy | SVP | M - OptEx | $0.00 | -8,000 | 65.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-08-03 | M | A | 8,000 | $75.90 | 30,926 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-08-03 | S | D | 8,000 | $122.50 | 22,926 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2021-08-03 | M | D | 8,000 | $0.00 | 64,978 | D | $75.90 · 2020-02-22 to 2029-02-21 | 8,000 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |